Cooper Pre-Tax Profit Margin 2010-2024 | COO

Current and historical pre-tax profit margin for Cooper (COO) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Cooper pre-tax profit margin for the three months ending January 31, 2024 was .
Cooper Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-01-31 $3.67B $0.41B 11.21%
2023-10-31 $3.59B $0.41B 11.49%
2023-07-31 $3.51B $0.38B 10.79%
2023-04-30 $3.43B $0.38B 11.00%
2023-01-31 $3.38B $0.48B 14.05%
2022-10-31 $3.31B $0.48B 14.36%
2022-07-31 $3.22B $0.53B 16.31%
2022-04-30 $3.14B $0.50B 15.99%
2022-01-31 $3.03B $0.47B 15.65%
2021-10-31 $2.92B $0.49B 16.83%
2021-07-31 $2.85B $0.46B 16.30%
2021-04-30 $2.66B $0.44B 16.38%
2021-01-31 $2.47B $0.31B 12.53%
2020-10-31 $2.43B $0.27B 10.94%
2020-07-31 $2.44B $0.30B 12.33%
2020-04-30 $2.54B $0.36B 14.24%
2020-01-31 $2.67B $0.48B 18.01%
2019-10-31 $2.65B $0.48B 18.02%
2019-07-31 $2.61B $0.46B 17.68%
2019-04-30 $2.59B $0.43B 16.38%
2019-01-31 $2.57B $0.35B 13.65%
2018-10-31 $2.53B $0.33B 13.11%
2018-07-31 $2.44B $0.32B 12.93%
2018-04-30 $2.34B $0.33B 14.28%
2018-01-31 $2.23B $0.39B 17.49%
2017-10-31 $2.14B $0.40B 18.47%
2017-07-31 $2.10B $0.37B 17.51%
2017-04-30 $2.06B $0.35B 17.13%
2017-01-31 $2.02B $0.33B 16.11%
2016-10-31 $1.97B $0.30B 15.04%
2016-07-31 $1.91B $0.26B 13.81%
2016-04-30 $1.85B $0.22B 11.61%
2016-01-31 $1.80B $0.20B 11.04%
2015-10-31 $1.80B $0.22B 11.96%
2015-07-31 $1.81B $0.21B 11.82%
2015-04-30 $1.78B $0.26B 14.78%
2015-01-31 $1.76B $0.28B 16.16%
2014-10-31 $1.72B $0.30B 17.24%
2014-07-31 $1.66B $0.32B 19.39%
2014-04-30 $1.64B $0.32B 19.44%
2014-01-31 $1.61B $0.31B 19.22%
2013-10-31 $1.59B $0.31B 19.65%
2013-07-31 $1.57B $0.33B 21.25%
2013-04-30 $1.54B $0.31B 20.42%
2013-01-31 $1.50B $0.30B 19.88%
2012-10-31 $1.45B $0.28B 19.10%
2012-07-31 $1.41B $0.26B 18.16%
2012-04-30 $1.38B $0.23B 16.92%
2012-01-31 $1.36B $0.21B 15.48%
2011-10-31 $1.33B $0.19B 14.51%
2011-07-31 $1.28B $0.18B 14.35%
2011-04-30 $1.23B $0.18B 14.59%
2011-01-31 $1.19B $0.14B 11.84%
2010-10-31 $1.16B $0.12B 10.71%
2010-07-31 $1.13B $0.10B 9.04%
2010-04-30 $1.12B $0.08B 7.25%
2010-01-31 $1.09B $0.11B 10.10%
2009-10-31 $1.08B $0.12B 10.65%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.860B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.42
Align Technology (ALGN) United States $19.244B 37.15
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00